Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

Am J Hematol. 2013 Jun;88(6):533-4. doi: 10.1002/ajh.23440. Epub 2013 May 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects
  • Consolidation Chemotherapy
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Remission Induction

Substances

  • Antimetabolites, Antineoplastic
  • Immunosuppressive Agents
  • Cytarabine